M

Myomo Inc
F:0M61

Watchlist Manager
Myomo Inc
F:0M61
Watchlist
Price: 0.721 EUR -3.99% Market Closed
Market Cap: €15.2m

Net Margin

-22.9%
Current
Improving
by 18.6%
vs 3-y average of -41.4%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-22.9%
=
Net Income
$-9.3m
/
Revenue
$40.8m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-22.9%
=
Net Income
€-9.3m
/
Revenue
$40.8m

Peer Comparison

Country Company Market Cap Net
Margin
US
Myomo Inc
AMEX:MYO
30.7m USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
185.8B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
184.4B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
137.3B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.8B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129.8B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.6B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.7B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.6B USD
Loading...

Market Distribution

Lower than 76% of companies in the United States of America
Percentile
24th
Based on 15 072 companies
24th percentile
-22.9%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Myomo Inc
Glance View

Market Cap
15.2m EUR
Industry
Health Care

Myomo, Inc. is a medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The company is headquartered in Boston, Massachusetts and currently employs 100 full-time employees. The company went IPO on 2017-06-12. The firm offers functional improvement for those with neuromuscular disorders and upper limb paralysis. The firm develops and markets the MyoPro product line. The MyoPro is a myoelectric-controlled upper limb brace (orthosis). The orthosis is a rigid brace used for the purpose of supporting a patient’s weak or paralyzed arm to enable and help improve functional activities of daily living (ADLs), in the home and community. The MyoPro can enable individuals to self-initiate and control movements of a partially paralyzed or weakened limb using their own muscle signals. The Company’s products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury and other neurological disorders. The company primarily provides devices directly to patients and bills their insurance companies.

0M61 Intrinsic Value
1.501 EUR
Undervaluation 52%
Intrinsic Value
Price
M
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-22.9%
=
Net Income
$-9.3m
/
Revenue
$40.8m
What is Myomo Inc's current Net Margin?

The current Net Margin for Myomo Inc is -22.9%, which is above its 3-year median of -41.4%.

How has Net Margin changed over time?

Over the last 3 years, Myomo Inc’s Net Margin has increased from -69.9% to -22.9%. During this period, it reached a low of -76.7% on Sep 30, 2022 and a high of -15% on Mar 31, 2025.

Back to Top